Clinical Trials Directory

Trials / Completed

CompletedNCT02831647

Acceptability and Tolerance Study of New Oral Nutritional Supplement PRAGUE

Tolerance and Acceptability of AYMES PRAGUE

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Aymes International Limited · Industry
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Tolerance and Acceptability of new oral nutritional supplement - AYMES PRAGUE

Detailed description

To evaluate tolerance and acceptability of AYMES PRAGUE in patients requiring supplementary oral nutritional support compared with currently available alternatives, measuring outcomes of GI effects, Compliance, product preference,convenience etc. To obtain data to support an ACBS submissions for AYMES PRAGUE (to allow for prescription in the community at NHS expense).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAYMES PRAGUEAYMES PRAGUE is a ready to drink, high energy, low volume oral nutritional supplement drink. It provides 300 kcal and 12g protein per 125ml serving. It is a Food for Special Medical Purposes (FSMP) and must therefore be used under medical supervision. It is not designed as a sole source of nutrition.

Timeline

Start date
2016-09-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-07-13
Last updated
2020-01-09

Source: ClinicalTrials.gov record NCT02831647. Inclusion in this directory is not an endorsement.